Ebola Virus Disease Overview and Definition

Symptoms and Transmission

Symptoms and Transmission of Ebola Virus Disease

The symptoms and transmission of Ebola virus disease (EVD) are critical topics for anyone traveling to or residing in regions where outbreaks occur. This page provides a comprehensive overview for international patients, healthcare professionals, and caregivers who need clear, evidence‑based information. Ebola remains one of the most severe viral hemorrhagic fevers, with a case‑fatality rate that can exceed 50 % without prompt medical care. Understanding how the disease presents and spreads enables quicker diagnosis, effective isolation, and timely treatment—key steps that can save lives.

In this guide you will discover the typical clinical progression of EVD, the primary routes through which the virus is transmitted, and practical measures to protect yourself and your loved ones. The information is aligned with World Health Organization (WHO) recommendations and reflects the standards of care provided at Liv Hospital for international patients seeking specialized infectious disease support.

Whether you are preparing for travel, assisting a patient, or simply seeking reliable health information, the following sections will equip you with the knowledge needed to recognize early warning signs and to understand the mechanisms that drive Ebola’s spread.

Early Clinical Presentation: Recognizing Initial Symptoms

The first step in managing Ebola is early detection. The early symptoms often resemble those of common viral infections, which can delay diagnosis. Within 2–21 days after exposure, patients typically experience:

• Fever (≥38.5 °C / 101.3 °F)
• Severe headache
• Muscle pain and weakness
• Fatigue and malaise
• Sore throat

These nonspecific signs are followed by gastrointestinal manifestations such as vomiting, diarrhea, and abdominal pain. As the disease progresses, more distinctive features appear, including:

• Bleeding from gums, eyes, or nose
• Rash or bruising
• Multi‑organ failure

Because early symptoms overlap with malaria, influenza, and other endemic illnesses, clinicians rely on a detailed exposure history and laboratory testing (RT‑PCR) to confirm Ebola. Prompt recognition enables isolation and supportive care, which are vital for improving survival odds.

Advanced Disease Stages: Severe Symptoms and Complications

When Ebola advances beyond the initial phase, patients may develop life‑threatening complications. The virus attacks the vascular system, leading to increased permeability, hypovolemia, and shock. Key severe symptoms include:

Supportive therapy focuses on maintaining fluid balance, electrolyte homeostasis, and oxygenation. Experimental treatments such as monoclonal antibodies (e.g., Inmazeb) have shown promise, but access may be limited in outbreak settings. Continuous monitoring in a high‑level isolation unit—like those available through Liv Hospital’s international patient program—optimizes outcomes.

Primary Modes of Transmission: How Ebola Spreads

Understanding the transmission pathways of Ebola is essential for prevention. The virus spreads through direct contact with:

1. Blood or bodily fluids (vomit, diarrhea, urine, saliva, sweat, semen) of a symptomatic person.
2. Contaminated surfaces or objects (needles, syringes, clothing).
3. Infected animal reservoirs, primarily fruit bats, and through handling of bushmeat.

Transmission does not occur via airborne droplets or casual contact, which distinguishes Ebola from respiratory viruses. However, the virus can persist in immune‑privileged sites (e.g., testes, eyes) for weeks after recovery, creating a risk of sexual transmission. Proper use of personal protective equipment (PPE), strict hand hygiene, and safe burial practices are proven methods to interrupt the chain of infection.

Infection Control Measures for Travelers and Healthcare Workers

Both travelers to endemic regions and healthcare workers must adopt rigorous infection control protocols. Key measures include:

• Pre‑travel vaccination (if available) and health counseling.
• Use of WHO‑approved PPE: impermeable gowns, double gloves, face shields, and N95 respirators.
• Immediate isolation of any person presenting with fever and a history of exposure.
• Safe disposal of sharps and contaminated waste in puncture‑proof containers.
• Post‑exposure monitoring for 21 days, with daily temperature checks.

Liv Hospital offers a dedicated international patient service that coordinates medical evacuation, quarantine facilities, and specialist consultation for individuals returning from high‑risk areas. This comprehensive approach ensures that anyone potentially exposed receives rapid assessment and, if necessary, treatment in a controlled environment.a

Diagnostic Approaches and Laboratory Testing

Accurate diagnosis of Ebola hinges on timely laboratory confirmation. The gold‑standard test is reverse transcription polymerase chain reaction (RT‑PCR), which detects viral RNA in blood samples. Other methods include:

• Antigen‑capture ELISA – useful for early detection but less sensitive.
• Virus isolation – performed in Biosafety Level‑4 (BSL‑4) labs, reserved for research.
• Serology – detects antibodies, indicating past infection rather than active disease.

Specimen collection must follow strict biosafety protocols to protect laboratory personnel. Samples are typically drawn during the acute febrile phase when viral loads are highest. Liv Hospital’s partnership with accredited international laboratories ensures rapid turnaround times, enabling clinicians to initiate appropriate isolation and therapeutic interventions without delay.

Why Choose Liv Hospital

Liv Hospital provides JCI‑accredited, 360‑degree care for international patients facing complex infectious diseases like Ebola. Our multidisciplinary team combines expertise in infectious disease, critical care, and advanced isolation technologies. We coordinate appointments, transportation, interpreter services, and comfortable accommodation, allowing patients and families to focus on recovery. With a commitment to evidence‑based medicine and personalized support, Liv Hospital stands as a trusted partner for those seeking world‑class treatment abroad.

Ready to discuss your health concerns or arrange a consultation with our infectious disease specialists? Contact Liv Hospital today to benefit from our comprehensive international patient services and take the first step toward safe, expert care.

Diagnosis and Evaluation

Rapid and accurate Ebola diagnosis at Liv Hospital ensures safe evaluation, isolation, and expert care for international patients.

Diagnosis and Evaluation of Ebola Virus Disease

Diagnosis and evaluation of Ebola virus disease (EVD) is a critical step in containing outbreaks and providing timely care to patients. This page is designed for international patients, healthcare professionals, and caregivers seeking clear, evidence‑based information on how EVD is identified and assessed in a modern clinical setting. According to the World Health Organization, the case‑fatality rate of Ebola can exceed 50 % without rapid diagnosis and supportive treatment. Understanding the full diagnostic pathway—from initial clinical suspicion to confirmatory laboratory results—helps ensure that patients receive the appropriate isolation, therapy, and follow‑up care.

In the following sections, we will explore the systematic approach used by leading infectious‑disease centers, including the role of symptom assessment, laboratory techniques such as reverse transcription polymerase chain reaction (RT‑PCR), imaging tools, differential diagnosis, and the strict biosafety measures that protect both patients and healthcare workers. By the end of this guide, you will have a comprehensive view of the diagnostic journey for Ebola virus disease and know how Liv Hospital’s international patient services support each step.

Clinical Presentation and Initial Assessment

The first pillar of diagnosis and evaluation is a thorough clinical assessment. Patients suspected of EVD typically present with a combination of systemic and hemorrhagic symptoms that evolve over a 2‑ to 21‑day incubation period. Early recognition hinges on detailed history‑taking and physical examination.

Key Symptoms to Recognize

• Fever ≥38 °C (often abrupt onset)
• Severe headache and muscle pain
• Vomiting, diarrhea, and abdominal pain
• Bleeding from mucous membranes, gums, or injection sites
• Fatigue, weakness, and unexplained rash

In addition to symptomatology, epidemiological factors are vital. Travel to or residence in an area with a known Ebola outbreak, contact with infected individuals, or exposure to contaminated bodily fluids dramatically raises pre‑test probability.

During the initial assessment, clinicians use a standardized checklist to capture both clinical and exposure data. This structured approach ensures that no critical detail is missed, which is essential for prompt isolation and further testing.

When the clinical suspicion is high, the patient is placed in an isolation unit, and the diagnostic workflow proceeds to laboratory confirmation.

Laboratory Testing for Ebola Virus

Laboratory confirmation is the definitive element of diagnosis and evaluation. The gold‑standard test for Ebola virus disease is the reverse transcription polymerase chain reaction (RT‑PCR), which detects viral RNA with high sensitivity and specificity.

Specimen Types and Collection

• Whole blood (preferred for early detection)
• Plasma or serum
• Urine and saliva (adjunctive, lower viral load)
• Swabs from lesions or mucosal surfaces

Specimens must be collected using PPE‑compliant techniques and placed in viral transport media. Time from collection to processing should be minimized to preserve RNA integrity.

In addition to RT‑PCR, rapid antigen detection tests (RDTs) are employed in field settings for preliminary screening, though they require confirmation by molecular methods.

Positive RT‑PCR results trigger immediate public‑health notification and initiation of supportive care protocols, while negative results in a high‑risk patient may prompt repeat testing after 48 hours.

Imaging and Ancillary Diagnostic Tools

Although imaging does not confirm Ebola virus infection, it plays a supportive role in diagnosis and evaluation by identifying complications such as organ dysfunction, hemorrhage, or secondary infections.

Common Imaging Modalities

• Chest X‑ray: Detects pulmonary edema, pneumonia, or pleural effusion.
• Ultrasound: Evaluates abdominal fluid collections, liver size, and vascular integrity.
• CT Scan: Reserved for severe cases to assess cerebral edema or intracranial hemorrhage.

Point‑of‑care ultrasound (POCUS) is especially valuable in resource‑limited settings because it can be performed at bedside with minimal equipment, reducing patient transport risks.

All imaging procedures must be performed in designated isolation zones with equipment decontaminated according to WHO biosafety guidelines.

Differential Diagnosis and Exclusion Criteria

Accurate diagnosis and evaluation requires distinguishing Ebola virus disease from other febrile illnesses that share similar presentations, especially in endemic regions.

Common Mimickers

• Malaria (Plasmodium falciparum)
• Lassa fever
• Marburg virus disease
• Typhoid fever
• Dengue hemorrhagic fever

Clinicians use a combination of epidemiologic context, symptom pattern, and targeted laboratory panels to rule out these alternatives. For example, a rapid malaria antigen test can be performed simultaneously with Ebola RT‑PCR to avoid missing co‑infection.

Exclusion criteria are documented in a decision‑tree format to guide clinicians through stepwise testing. This systematic approach reduces diagnostic delay and prevents unnecessary isolation of patients with unrelated conditions.

By systematically excluding these conditions, the healthcare team can focus resources on confirmed Ebola cases and initiate appropriate infection‑control measures.

Biosafety Protocols During Diagnostic Procedures

• Ensuring the safety of laboratory staff and clinicians is an integral component of diagnosis and evaluation. Ebola virus is classified as a Biosafety Level 4 (BSL‑4) pathogen, demanding the highest containment standards.

  Personal Protective Equipment (PPE) Requirements

  • Impermeable gown or coverall
  • Double gloves with inner nitrile and outer heavy‑duty
  • Full face shield or goggles
  • Powered air‑purifying respirator (PAPR) or N95 mask with a surgical mask overlay
  • Boot covers and head protection

  All specimen handling occurs within certified biosafety cabinets (Class II). Decontamination procedures include 0.5 % sodium hypochlorite soaking for at least 30 minutes before disposal.

  Step	Action	Safety Measure
  Specimen receipt	Log and label in BSL‑4 area	Double‑glove technique
  Processing	RNA extraction in biosafety cabinet	UV decontamination of work surface
  Waste disposal	Autoclave or incinerate	Seal in leak‑proof containers

  Liv Hospital’s international patient program coordinates with local health authorities to ensure that all biosafety protocols meet or exceed WHO recommendations, protecting both patients and staff throughout the diagnostic journey.

Interpreting Results and Next Steps in Patient Management

• Once laboratory data are available, the final phase of diagnosis and evaluation involves result interpretation, communication, and initiation of care pathways.

  Result Categories

  • Positive RT‑PCR: Confirmed Ebola virus disease; immediate isolation and supportive therapy.
  • Negative RT‑PCR with high clinical suspicion: Repeat testing after 48 hours; consider alternative diagnoses.
  • Inconclusive/Indeterminate: Verify specimen integrity; repeat collection if possible.

  For confirmed cases, Liv Hospital offers a comprehensive treatment package that includes fluid and electrolyte management, experimental antiviral therapy where available, and psychological support for patients and families. International patients benefit from coordinated travel assistance, interpreter services, and accommodation arrangements while undergoing care.

  Result	Clinical Action	Patient Support Services
  Positive	Start isolation, supportive care, consider experimental drugs	24/7 medical liaison, translation, accommodation
  Negative (high suspicion)	Repeat RT‑PCR, broaden differential, monitor vitals	Tele‑consultation, travel coordination
  Inconclusive	Validate sample, repeat collection	Logistical support for repeat testing

  Clear communication of results is essential. Liv Hospital’s patient‑centered approach ensures that families receive timely, understandable explanations, and that any necessary public‑health notifications are handled discreetly and efficiently.

Why Choose Liv Hospital ?

Liv Hospital combines JCI accreditation, cutting‑edge infectious‑disease expertise, and a dedicated international patient service team. Our multidisciplinary specialists are experienced in managing high‑risk viral illnesses, including Ebola, within a safe, culturally sensitive environment. From seamless appointment scheduling to personalized interpreter support and comfortable accommodation, we provide a 360‑degree care experience that prioritizes both medical excellence and patient comfort.

Ready to take the next step in your healthcare journey? Contact Liv Hospital today to arrange a consultation with our infectious‑disease specialists and discover how our comprehensive services can support you throughout diagnosis, treatment, and recovery.

Treatment and Management

Treatment and Management of Ebola Virus Disease

Treatment and management of Ebola virus disease is critical for reducing mortality and preventing further transmission. This page provides a comprehensive overview for international patients, healthcare professionals, and families seeking clear guidance on how the disease is handled in a modern, JCI‑accredited setting. With a case‑fatality rate that can exceed 50 % in untreated outbreaks, timely and coordinated care can dramatically improve outcomes.

Readers will learn about the core components of supportive care, the latest antiviral and experimental options, infection‑control protocols, and strategies for handling complications. We also outline post‑recovery monitoring and the unique advantages of receiving care at Liv Hospital, where a dedicated international patient team ensures seamless coordination from admission to discharge.

Whether you are preparing for possible exposure, coordinating care for a loved one, or simply seeking reliable information, this guide equips you with the essential knowledge to navigate the complexities of Ebola virus disease treatment and management.

Understanding Ebola Virus Disease: Clinical Overview

Ebola virus disease (EVD) is a severe, often fatal illness caused by the Ebola virus, a member of the Filoviridae family. Transmission occurs through direct contact with the blood, secretions, organs, or other bodily fluids of infected individuals, as well as through contaminated surfaces and objects.

Key clinical features typically appear 2–21 days after exposure and include:

• High fever and severe headache
• Muscle pain and weakness
• Vomiting, diarrhea, and abdominal pain
• Unexplained hemorrhage (internal or external)
• Multi‑organ dysfunction in advanced stages

Early recognition is essential because the disease progresses rapidly. Laboratory confirmation relies on reverse‑transcription polymerase chain reaction (RT‑PCR) testing of blood samples. Prompt isolation and initiation of treatment and management protocols are the first steps in controlling an outbreak.

Supportive Care as the Foundation of Treatment and Management

In the absence of a universally approved cure, supportive care remains the cornerstone of Ebola treatment. The primary goals are to maintain fluid balance, correct electrolyte disturbances, and support organ function while the immune system combats the virus.

Key supportive interventions include:

Continuous monitoring of vital signs, renal output, and coagulation parameters allows clinicians to adjust therapy promptly. In high‑resource settings such as Liv Hospital, advanced hemodynamic monitoring and bedside ultrasound enhance the precision of supportive measures.

Antiviral and Experimental Therapies

While supportive care is essential, several antiviral agents and monoclonal antibody preparations have demonstrated efficacy in clinical trials and are now incorporated into treatment and management protocols for Ebola.

Current investigational and approved options include:

• Inmazeb (atoltivimab, maftivimab, odesivimab) – a triple‑antibody cocktail targeting the viral glycoprotein.
• Ebanga (ansuvimab) – a single monoclonal antibody with proven survival benefit.
• Remdesivir – a broad‑spectrum antiviral RNA polymerase inhibitor, used under compassionate use.
• Favipiravir – an oral antiviral evaluated in several outbreak settings.
• Convalescent plasma – plasma from recovered patients containing neutralizing antibodies.

Administration protocols vary, but most therapies are given intravenously early in the disease course, ideally within the first 72 hours of symptom onset. Combination therapy with antibodies and antivirals is an area of active research, and Liv Hospital’s participation in international clinical trials ensures patients have access to cutting‑edge options.

Infection Control Measures in Clinical Settings

Effective treatment and management of Ebola cannot succeed without rigorous infection‑control practices. Protecting healthcare workers and preventing nosocomial spread are paramount.

Liv Hospital’s infection‑control team conducts daily audits, ensuring compliance with World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) guidelines. Immediate reporting mechanisms are in place for any breach, allowing rapid response to contain potential exposures.

Managing Complications and Organ Support

• Severe Ebola cases often develop complications that require targeted organ‑support strategies. Early identification and intervention can reduce mortality.

  • Acute Kidney Injury (AKI) – Managed with renal replacement therapy (hemodialysis or continuous veno‑venous hemofiltration) when creatinine rises sharply.
  • Coagulopathy – Replacement of clotting factors, platelet transfusions, and careful monitoring of PT/INR.
  • Respiratory Failure – Non‑invasive ventilation progressing to invasive mechanical ventilation if oxygenation fails.
  • Neurological Sequelae – Neuro‑imaging and antiepileptic medications for seizures or encephalitis.
  • Cardiovascular Shock – Vasopressor support (norepinephrine or dopamine) alongside fluid resuscitation.

  Multidisciplinary rounds involving intensivists, nephrologists, hematologists, and infectious‑disease specialists ensure that each organ system receives appropriate attention. Liv Hospital’s intensive care unit is equipped with bedside renal‑replacement machines, advanced ventilators, and a pharmacy stocked with emergency blood products.

Post‑Recovery Follow‑Up and Rehabilitation

Survivors of Ebola may experience long‑term sequelae, including joint pain, vision problems, and psychological distress. Structured follow‑up is an essential component of comprehensive treatment and management plans.

Liv Hospital offers a dedicated survivorship clinic where multidisciplinary teams provide continuity of care, counseling, and access to clinical trials investigating long‑term outcomes. Tele‑medicine options are also available for patients returning to their home countries.

Why Choose Liv Hospital

Liv Hospital combines JCI accreditation with a specialized international patient program, ensuring that every aspect of Ebola treatment and management is delivered with the highest standards of safety and compassion. Our expert infectious‑disease physicians, state‑of‑the‑art isolation facilities, and coordinated logistics—from airport transfer to interpreter services—create a seamless experience for patients traveling from abroad.

By integrating cutting‑edge therapies, rigorous infection control, and comprehensive post‑recovery support, Liv Hospital stands out as a trusted destination for those seeking world‑class care for complex infectious diseases.

Take the next step toward expert Ebola care. Contact our International Patient Services team today to arrange a personalized consultation, secure travel assistance, and begin your journey toward recovery with Liv Hospital.

Prevention and Control

Guidance on preventing Ebola, including vaccination and safety measures, with international patient support from Liv Hospital.

Prevention and Control of Ebola Virus Disease

The Prevention and Control of Ebola virus disease (EVD) is a critical priority for health systems worldwide, especially for international travelers and expatriates who may encounter outbreaks in endemic regions. With a case‑fatality rate that can exceed 50 %, understanding how to stop the spread of this hemorrhagic fever is essential for both healthcare professionals and the general public. According to the World Health Organization, early implementation of comprehensive prevention measures can reduce transmission by up to 80 % when combined with rapid case identification.

This page provides a detailed guide on the most effective strategies to prevent and control Ebola, tailored for an international audience seeking reliable medical information. We cover the science of transmission, protective protocols for medical staff, community‑level interventions, vaccination options, environmental safety, and the importance of robust surveillance systems. Whether you are a traveler planning a visit to a high‑risk area, a clinician preparing to treat suspected cases, or a public‑health official coordinating response efforts, the information here equips you with evidence‑based practices to safeguard health.

By integrating these measures, patients and providers can work together to limit outbreaks, protect vulnerable populations, and ensure that care remains safe and effective across borders.

Understanding Ebola Transmission Dynamics

Effective Prevention and Control begins with a clear grasp of how Ebola spreads. The virus is transmitted through direct contact with the blood, secretions, organs, or other bodily fluids of infected individuals, as well as with contaminated objects such as needles.

Modes of Transmission

• Direct contact with infected blood or body fluids.
• Exposure to contaminated surfaces (fomites) and medical equipment.
• Traditional burial practices involving close contact with the deceased.
• Rarely, transmission through mucous membranes or broken skin.

Understanding the incubation period is also vital. Symptoms typically appear 2–21 days after exposure, during which the infected person may not yet be contagious. Below is a concise comparison of key timelines:

By recognizing these patterns, health workers can implement timely isolation and reduce the risk of onward transmission, forming the cornerstone of any Prevention and Control program.

Standard Precautions for Healthcare Workers

Healthcare personnel are at the front line of Ebola Prevention and Control. Strict adherence to infection‑control protocols protects both staff and patients.

Personal Protective Equipment (PPE) Requirements

The following PPE ensemble is recommended for any direct patient care involving suspected or confirmed Ebola cases:

• Impermeable gown or coverall.
• Double gloves (inner nitrile, outer latex).
• Full‑face shield or goggles.
• Fluid‑resistant boot covers.
• Respiratory protection (N95 respirator or powered air‑purifying respirator).

A clear hierarchy of PPE levels helps staff choose the appropriate protection based on exposure risk:

Training on donning and doffing techniques, along with supervised practice sessions, reduces self‑contamination risk by up to 70 %. Continuous monitoring and immediate correction of breaches are essential components of a robust Prevention and Control framework in clinical settings.

Community‑Based Prevention Strategies

Outbreaks are curtailed most effectively when whole communities adopt preventive behaviors. Public‑health campaigns must be culturally sensitive and involve local leaders to achieve lasting impact.

Safe Burial Practices

Traditional burial rituals often involve washing and touching the body, which can amplify transmission. Safe burial protocols replace these practices with the following steps:

• Use of body bags that are sealed and disinfected.
• Training of burial teams in PPE use.
• Community education on the risks of direct contact.
• Provision of culturally appropriate rituals that do not involve physical contact.

Other community measures include:

• Establishing hand‑washing stations with chlorine‑based solutions.
• Promoting the use of personal protective equipment for caregivers at home.
• Disseminating clear messages about symptom recognition and early reporting.

The table below outlines typical community interventions and their projected impact on transmission rates:

When these strategies are combined with rapid case detection, the overall Prevention and Control of Ebola in affected regions improves dramatically, often halting outbreaks within weeks.

Vaccination and Post‑Exposure Prophylaxis

Vaccination represents a powerful tool in the arsenal of Ebola Prevention and Control. The recombinant vesicular stomatitis virus‑Zaire Ebola virus (rVSV‑ZEBOV) vaccine has demonstrated high efficacy in clinical trials.

Available Vaccines

• rVSV‑ZEBOV – single‑dose, administered intramuscularly.
• Ad26.ZEBOV/MVA‑BNS – two‑dose regimen under investigation.

Vaccination can be applied in two primary contexts:

• Pre‑exposure prophylaxis (PrEP) for healthcare workers, laboratory staff, and residents of high‑risk areas.
• Post‑exposure prophylaxis (PEP) for individuals with known contact to a confirmed case, ideally within 72 hours.

The schedule for the most widely used rVSV‑ZEBOV vaccine is summarized below:

While vaccines are a cornerstone of long‑term Prevention and Control, they must be integrated with other measures such as surveillance and infection‑control practices to achieve comprehensive protection.

Environmental Decontamination and Waste Management

• Surfaces and medical waste can serve as hidden reservoirs for Ebola, making rigorous decontamination essential for successful Prevention and Control.

  Effective Disinfectants

  • 0.5 % chlorine solution (1,000 ppm) – recommended for routine cleaning.
  • 2 % glutaraldehyde – for high‑risk equipment.
  • Alcohol‑based solutions (≥70 %) – for small surfaces.

  Cleaning protocols should follow a three‑step process: removal of organic material, application of disinfectant, and proper contact time (usually 10 minutes for chlorine).

  A concise waste‑management workflow helps prevent accidental exposure:

  Step	Action	Safety Measures
  Segregation	Separate infectious from non‑infectious waste.	PPE for all personnel handling waste.
  Packaging	Use double‑layered, leak‑proof containers.	Label with biohazard symbols.
  Transport	Designated routes and vehicles.	Secure containment during movement.
  Disposal	Incineration or autoclaving.	Document disposal logs for traceability.

  Adhering to these standards minimizes environmental contamination and protects both staff and the wider community, reinforcing the overall Prevention and Control strategy.

Monitoring, Surveillance, and Rapid Response

Timely detection of cases and swift containment actions are the backbone of Ebola Prevention and Control. Robust surveillance systems enable health authorities to track the spread and allocate resources efficiently.

Contact Tracing Workflow

• Identify all individuals who had direct exposure to a confirmed case.
• Classify contacts as high‑ or low‑risk based on exposure level.
• Implement daily monitoring for 21 days, recording temperature and symptoms.
• Provide immediate isolation and medical evaluation for any symptomatic contact.

The table below outlines a typical rapid‑response timeline from case confirmation to community containment:

Integrating real‑time data dashboards, mobile reporting tools, and international collaboration ensures that each step of the response is coordinated, transparent, and effective—key pillars of comprehensive Prevention and Control.

Why Choose Liv Hospital ?

Liv Hospital offers world‑class care for international patients facing complex health challenges, including infectious diseases like Ebola. As a JCI‑accredited facility in Istanbul, we combine cutting‑edge medical expertise with a dedicated 360‑degree support system that handles appointments, transportation, interpreter services, and comfortable accommodation. Our multidisciplinary teams are experienced in infection control, ensuring that you receive safe, evidence‑based treatment in a culturally sensitive environment.

Take the first step toward safe, expert care. Contact Liv Hospital today to discuss your health needs and learn how our international patient services can support you throughout your treatment journey.